GlassScriptPhysician profile
Chad A Drey
NPI 1518096742
$3,890.29
in general payments reported to CMS, 2019-2025
30 companies · $550 in 2025
The $550 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $119 · 2021: $195 · 2022: $288 · 2023: $1,832 · 2024: $391 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Consulting Fee: $1,300 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.25 |
| Consulting Fee | $1,300.00 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,300.00 | 2023 | |
| Astellas Pharma US INC | $350.65 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $306.15 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Boston Scientific Corporation | $258.44 | 2019-2025 | Upsylon, General - Female Sui |
| Intuitive Surgical, INC. | $230.01 | 2019-2023 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $216.91 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $136.11 | 2022-2025 | |
| Daiichi Sankyo INC. | $127.87 | 2019-2024 | Injectafer |
| Conmed Corporation | $108.90 | 2022 | |
| Teleflex LLC | $107.34 | 2019-2021 | |
| Coopersurgical, INC. | $100.72 | 2021 | |
| Exeltis, USA INC. | $64.10 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $62.71 | 2019-2025 | |
| Organon LLC | $57.90 | 2023-2024 | Nexplanon |
| Avion Pharmaceuticals | $53.30 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $47.38 | 2024 | Axonics, Bulkamid |
| Pfizer INC. | $46.84 | 2023-2025 | |
| Myovant Sciences INC. | $45.43 | 2022 | |
| Allergan, INC. | $41.42 | 2019 | |
| Amgen INC. | $39.12 | 2019 | |
| Therapeuticsmd, INC. | $37.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.03 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $23.03 | 2019 | |
| Roche Diagnostics Corporation | $19.92 | 2019 | |
| Hologic Sales and Service, LLC | $17.88 | 2023 | Coolseal Generator, Acessa Provu System |
| Novo Nordisk INC | $16.23 | 2023 | Wegovy |
| Dexcom, INC. | $14.38 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $13.27 | 2019 | |
| Lupin INC. | $11.65 | 2019 | |
| Olympus America INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Drey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.